Andrew N. Cornforth

793 total citations
31 papers, 624 citations indexed

About

Andrew N. Cornforth is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Andrew N. Cornforth has authored 31 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 23 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Andrew N. Cornforth's work include Immunotherapy and Immune Responses (22 papers), CAR-T cell therapy research (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Andrew N. Cornforth is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), CAR-T cell therapy research (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Andrew N. Cornforth collaborates with scholars based in United States, Panama and China. Andrew N. Cornforth's co-authors include Robert O. Dillman, Carol DePriest, Edward F. McClay, Patric M. Schiltz, Gabriel I. Nistor, Denysha Carbonell, Thomas Amatruda, Christopher Duma, Cristina de Leon and Kent L. Nastiuk and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Andrew N. Cornforth

31 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew N. Cornforth United States 16 398 398 238 62 54 31 624
Jiemiao Hu United States 15 327 0.8× 379 1.0× 172 0.7× 53 0.9× 80 1.5× 32 657
Shamaila Munir Ahmad Denmark 18 422 1.1× 514 1.3× 171 0.7× 116 1.9× 39 0.7× 29 790
Seila Lorenzo‐Herrero Spain 13 414 1.0× 475 1.2× 138 0.6× 75 1.2× 49 0.9× 26 714
Vidyalakshmi Chandramohan United States 11 301 0.8× 216 0.5× 289 1.2× 71 1.1× 32 0.6× 26 624
Troy A. Luster United States 12 195 0.5× 290 0.7× 352 1.5× 35 0.6× 53 1.0× 18 634
Annamaria De Filippo Italy 8 395 1.0× 445 1.1× 249 1.0× 23 0.4× 36 0.7× 9 685
Evelina Martinenaite Denmark 17 338 0.8× 450 1.1× 176 0.7× 109 1.8× 51 0.9× 33 734
Sarah C. Garrett-Thomson United States 8 497 1.2× 387 1.0× 188 0.8× 28 0.5× 71 1.3× 10 714
Monika Kusio-Kobiałka Poland 10 404 1.0× 360 0.9× 258 1.1× 46 0.7× 38 0.7× 15 761
Wade Anderson United States 4 210 0.5× 188 0.5× 284 1.2× 82 1.3× 42 0.8× 7 673

Countries citing papers authored by Andrew N. Cornforth

Since Specialization
Citations

This map shows the geographic impact of Andrew N. Cornforth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew N. Cornforth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew N. Cornforth more than expected).

Fields of papers citing papers by Andrew N. Cornforth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew N. Cornforth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew N. Cornforth. The network helps show where Andrew N. Cornforth may publish in the future.

Co-authorship network of co-authors of Andrew N. Cornforth

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew N. Cornforth. A scholar is included among the top collaborators of Andrew N. Cornforth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew N. Cornforth. Andrew N. Cornforth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dillman, Robert O., Andrew N. Cornforth, Gabriel I. Nistor, et al.. (2018). Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses. Journal for ImmunoTherapy of Cancer. 6(1). 19–19. 58 indexed citations
2.
Jadus, Martin R., Ahmed Aref, Neil Hoa, et al.. (2014). HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma. OncoTargets and Therapy. 7. 1061–1061. 13 indexed citations
3.
Hoa, Neil, Lisheng Ge, Rajeev B. Tajhya, et al.. (2014). Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease.. PubMed. 6(3). 188–205. 16 indexed citations
4.
Dillman, Robert O., Andrew N. Cornforth, & Gabriel Nistor. (2013). Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?. Expert Opinion on Biological Therapy. 13(5). 643–656. 23 indexed citations
5.
Ge, Lisheng, Andrew N. Cornforth, Neil Hoa, et al.. (2012). Differential Glioma-Associated Tumor Antigen Expression Profiles of Human Glioma Cells Grown in Hypoxia. PLoS ONE. 7(9). e42661–e42661. 14 indexed citations
6.
Dillman, Robert O., Andrew N. Cornforth, Carol DePriest, et al.. (2012). Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy. Journal of Immunotherapy. 35(8). 641–649. 60 indexed citations
7.
Cornforth, Andrew N., et al.. (2011). Characterization of Interferon-γ–Treated Melanoma Tumor Cells for Use in Dendritic Cell-Based Immunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 26(3). 345–351. 23 indexed citations
8.
Dillman, Robert O., Gary B. Fogel, Andrew N. Cornforth, et al.. (2011). Features Associated with Survival in Metastatic Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines. Cancer Biotherapy and Radiopharmaceuticals. 26(4). 407–415. 16 indexed citations
9.
Cornforth, Andrew N., et al.. (2011). Autologous Peripheral Blood Mononuclear Cell Recognition of Autologous Proliferating Tumor Cells in the Context of a Patient‐Specific Vaccine Trial. BioMed Research International. 2011(1). 635850–635850. 2 indexed citations
10.
Dillman, Robert O., Richard B. Kim, Christopher Duma, et al.. (2010). Durable Complete Response of Refractory, Progressing Metastatic Melanoma After Treatment with a Patient-Specific Vaccine. Cancer Biotherapy and Radiopharmaceuticals. 25(5). 553–557. 18 indexed citations
11.
12.
Hoa, Neil, Lisheng Ge, Yurii G. Kuznetsov, et al.. (2010). Glioma Cells Display Complex Cell Surface Topographies That Resist the Actions of Cytolytic Effector Lymphocytes. The Journal of Immunology. 185(8). 4793–4803. 22 indexed citations
13.
Dillman, Robert O., Senthamil R. Selvan, Patric M. Schiltz, et al.. (2009). Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report. Cancer Biotherapy and Radiopharmaceuticals. 24(3). 311–319. 56 indexed citations
14.
Dillman, Robert O., et al.. (2009). Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma. Journal of Immunotherapy. 32(9). 914–919. 78 indexed citations
15.
Cornforth, Andrew N., et al.. (2009). Increases in Serum TARC/CCL17 Levels Are Associated with Progression-Free Survival in Advanced Melanoma Patients in Response to Dendritic Cell-Based Immunotherapy. Journal of Clinical Immunology. 29(5). 657–664. 17 indexed citations
16.
Cornforth, Andrew N., et al.. (2008). FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells. Oncogene. 27(32). 4422–4433. 57 indexed citations
17.
Selvan, Senthamil R., Andrew N. Cornforth, Nagesh Rao, et al.. (2004). Establishment and characterization of a human primary prostate carcinoma cell line, HH870. The Prostate. 63(1). 91–103. 6 indexed citations
18.
Nayak, Shankar K., et al.. (2000). CHARACTERIZATION OF CANCER CELL LINES ESTABLISHED FROM TWO HUMAN METASTATIC BREAST CANCERS. In Vitro Cellular & Developmental Biology - Animal. 36(3). 188–188. 11 indexed citations
19.
Dillman, R O, Linda D. Beutel, Andrew N. Cornforth, & Shankar K. Nayak. (2000). Short-Term Tumor Cell Lines from Renal Cell Carcinoma for Use as Autologous Tumor Cell Vaccines in the Treatment of Kidney Cancer. Cancer Biotherapy and Radiopharmaceuticals. 15(2). 161–168. 15 indexed citations
20.
Beutel, Linda D., et al.. (1999). THE USE OF SHORT-TERM CULTURES OF AUTOLOGOUS TUMOR CELLS FOR CANCER VACCINE. Journal of Immunotherapy. 22(5). 457–457. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiemiao Hu Breakdown of academic impact, for papers by Shamaila Munir Ahmad Breakdown of academic impact, for papers by Seila Lorenzo‐Herrero Breakdown of academic impact, for papers by Vidyalakshmi Chandramohan Breakdown of academic impact, for papers by Troy A. Luster Breakdown of academic impact, for papers by Annamaria De Filippo Breakdown of academic impact, for papers by Evelina Martinenaite Breakdown of academic impact, for papers by Sarah C. Garrett-Thomson Breakdown of academic impact, for papers by Monika Kusio-Kobiałka Breakdown of academic impact, for papers by Wade Anderson
Rankless by CCL
2026